학술논문
Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment
Document Type
Abstract
Author
Dale, David C.; Alsina, Laia; Azar, Antoine; Badolato, Raffaele; Bhandari, Ashish; Belschner, Andrea; Bertrand, Yves; Cadavid, Diego; Dickerson, Kathryn E.; Ezra, Navid; Hasle, Henrik; Hoffman, Harold; Jiang, Honghua; Kang, Hyoung Jin; Kiani-Alikhan, Sorena; Kuijpers, Taco W.; Kulagin, Aleksandr D.; Langguth, Daman; Levin, Carina; MacLeod, Richard; Neth, Olaf; Peake, Jane; Rodina, Yulia; Sharathkumar, Anjali; Shcherbina, Anna; Tang, Weihua; Vossen, Matthias G.; Donadieu, Jean
Source
In Blood 23 November 2021 138 Supplement 1:4310-4310
Subject
Language
ISSN
0006-4971